Amedeo Smart

Free Medical Literature Service

 

Amedeo

Pancreatitis
  Free Subscription

Articles published in
N Engl J Med
    July 2026
  1. WOLPIN BM, Hong DS
    Daraxonrasib in Advanced RAS-Mutated Pancreatic Cancer. Reply.
    N Engl J Med. 2026;395:414.
    >> Share

  2. SUN X, Chen B, Wang S
    Daraxonrasib in Advanced RAS-Mutated Pancreatic Cancer.
    N Engl J Med. 2026;395:414.
    >> Share

  3. SIVAKUMAR S
    Breaking the RAS Barrier in Pancreatic Cancer.
    N Engl J Med. 2026;395:400-401.
    >> Share

    May 2026
  4. O'REILLY EM, Wainberg ZA, Hendifar AE, Borad MJ, et al
    Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
    N Engl J Med. 2026 May 31. doi: 10.1056/NEJMoa2605555.
    >> Share

  5. DER CJ, Yeh JJ
    Advances in RAS Therapeutics for Pancreatic Cancer.
    N Engl J Med. 2026;394:1857-1861.
    >> Share

  6. WOLPIN BM, Park W, Garrido-Laguna I, Spira A, et al
    Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer.
    N Engl J Med. 2026;394:1790-1802.
    >> Share

    April 2026
  7. MARSTON NA, Bergmark BA, Sabatine MS
    Olezarsen for Hypertriglyceridemia and Pancreatitis Risk. Reply.
    N Engl J Med. 2026;394:1763-1764.
    >> Share

  8. WANG S, Fan Z
    Olezarsen for Hypertriglyceridemia and Pancreatitis Risk.
    N Engl J Med. 2026;394:1763.
    >> Share

  9. CHEN R, Lu S, Chen M
    Olezarsen for Hypertriglyceridemia and Pancreatitis Risk.
    N Engl J Med. 2026;394:1762.
    >> Share

    March 2026
  10. TU ZL, Tu JF
    Walled-Off Pancreatic Necrosis.
    N Engl J Med. 2026;394:e22.
    >> Share

  11. PARK W, Kasi A, Spira AI, Paz-Ares Rodriguez L, et al
    Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer.
    N Engl J Med. 2026 Mar 25. doi: 10.1056/NEJMoa2600752.
    >> Share

    November 2025
  12. MARSTON NA, Bergmark BA, Alexander VJ, Prohaska TA, et al
    Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.
    N Engl J Med. 2025 Nov 8. doi: 10.1056/NEJMoa2512761.
    >> Share

    April 2025
  13. WATTS GF, Hegele RA, Leeper NJ
    Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk. Reply.
    N Engl J Med. 2025;392:1452-1453.
    >> Share

  14. SHIMAZU Y
    Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
    N Engl J Med. 2025;392:1452.
    >> Share

    January 2025
  15. STITZIEL NO
    Reducing the Risk of Pancreatitis by Inhibiting APOC3.
    N Engl J Med. 2025;392:197-199.
    >> Share

    November 2024
  16. GONDA TA, Cahen DL, Farrell JJ
    Pancreatic Cysts. Reply.
    N Engl J Med. 2024;391:2064.
    >> Share

  17. HAMADA T, Oyama H, Nakai Y
    Pancreatic Cysts.
    N Engl J Med. 2024;391:2063-2064.
    >> Share

    September 2024
  18. GONDA TA, Cahen DL, Farrell JJ
    Pancreatic Cysts.
    N Engl J Med. 2024;391:832-843.
    >> Share

  19. RUBIN EJ, Leopold J, Morrissey S
    NEJM at ESC - Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
    N Engl J Med. 2024 Sep 2. doi: 10.1056/NEJMe2410905.
    >> Share

  20. WATTS GF, Rosenson RS, Hegele RA, Goldberg IJ, et al
    Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
    N Engl J Med. 2024 Sep 2. doi: 10.1056/NEJMoa2409368.
    >> Share

    April 2024
  21. STROES ESG, Alexander VJ, Karwatowska-Prokopczuk E, Hegele RA, et al
    Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
    N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2400201.
    >> Share

    February 2024
  22. ALEXANDER VJ, Karwatowska-Prokopczuk E, Prohaska TA, Li L, et al
    Volanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia.
    N Engl J Med. 2024;390:476-477.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016